Dexcom (DXCM) Interest Coverage Ratio (QoQ) (2010 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 111.60% |
| Mar 31, 2023 | -61.54% |
| Dec 31, 2022 | -16.79% |
| Sep 30, 2022 | 95.72% |
| Jun 30, 2022 | 82.47% |
| Mar 31, 2022 | 6,932.97% |
| Dec 31, 2021 | -99.50% |
| Sep 30, 2021 | 22.22% |
| Jun 30, 2021 | 115.46% |
| Mar 31, 2021 | 498.15% |
| Dec 31, 2020 | -163.60% |
| Sep 30, 2020 | 15.47% |
| Jun 30, 2020 | 53.08% |
| Mar 31, 2020 | -67.11% |
| Dec 31, 2019 | 78.88% |
| Sep 30, 2019 | 7,053.64% |
| Jun 30, 2019 | 94.48% |
| Mar 31, 2019 | 95.19% |
| Dec 31, 2018 | -807.62% |
| Sep 30, 2018 | 377.88% |
| Jun 30, 2018 | 84.04% |
| Mar 31, 2018 | -350.50% |
| Dec 31, 2017 | 2,397.87% |
| Sep 30, 2017 | 97.47% |
| Jun 30, 2017 | 94.57% |
| Mar 31, 2017 | -297.38% |
| Dec 31, 2016 | 78.02% |
| Sep 30, 2016 | 53.98% |
| Jun 30, 2016 | -4.69% |
| Sep 30, 2015 | -1,077.78% |
| Jun 30, 2015 | 43.31% |
| Mar 31, 2015 | -893.75% |
| Dec 31, 2014 | 132.00% |
| Sep 30, 2014 | 13.79% |
| Jun 30, 2014 | 52.85% |
| Mar 31, 2014 | -702.17% |
| Dec 31, 2013 | 73.56% |
| Sep 30, 2013 | 41.41% |
| Jun 30, 2013 | 9.17% |
| Mar 31, 2013 | -31.33% |
| Dec 31, 2011 | 109.19% |
| Sep 30, 2011 | -440.32% |
| Jun 30, 2011 | -24.50% |
| Mar 31, 2011 | -899.65% |
| Dec 31, 2010 | 183.34% |
| Sep 30, 2010 | -419.01% |